Propensity Score–Adjusted Comparison of Long-Term Outcomes Among Revascularization Strategies For Critical Limb Ischemia
Propensity Score–Adjusted Comparison of Long-Term Outcomes Among Revascularization Strategies For Critical Limb Ischemia Jihad A. Mustapha, Barry T. Katzen, Richard F. Neville, Robert A. Lookstein, Thomas Zeller, Larry E. Miller, Teresa R. Nelson, Michael R. Jaff, On behalf of the Board of the CLI Global Society Background Few studies have compared long-term outcomes among specific […]
Critical Limb Ischemia: A Threat to Life and Limb
Critical Limb Ischemia: A Threat to Life and Limb Jihad A. Mustapha, MD; Barry T. Katzen, MD; Richard F. Neville, MD, FACS; Robert A. Lookstein, MD; Thomas Zeller, MD, PhD; Larry E. Miller, PhD; Vickie R. Driver, DPM; and Michael R. Jaff, DO Introduction Peripheral artery disease (PAD) of the lower extremities is a global […]
Worth an Arm and a Leg: The Critical Importance of Limb Ischemia
Worth an Arm and a Leg: The Critical Importance of Limb Ischemia Javier A. Valle, Stephen W. Waldo Introduction Critical limb ischemia (CLI) represents the final stages of peripheral artery disease, reflecting impairment in tissue perfusion that leads to a threatened limb. The clinical manifestations of this condition may be broad, ranging from rest pain […]
Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study
Determinants of Long‐Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population‐Based Cohort Study Jihad A. Mustapha, MD; Barry T. Katzen, MD; Richard F. Neville, MD; Robert A. Lookstein, MD; Thomas Zeller, MD; Larry E. Miller, PhD; and Michael R. Jaff, DO Background The optimal treatment for critical limb ischemia remains controversial […]